Titan Biotech Ltd, a small-cap specialty chemical firm, has proclaimed that the Board of Directors, during its meeting held on Saturday, 29th November, 2025 has announced 5:1 sub-division/split.
Read Full
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
